Scanning NSE · BSE · NYSE · NASDAQ

Ultragenyx Pharmaceutical Inc. - (RARE) share price

Ultragenyx Pharmaceutical Inc. - (NASDAQ:RARE) last traded at $15.43, down 0.90% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $1.57B and a 52-week range of $12.73 to $39.89.

Key facts for Ultragenyx Pharmaceutical Inc. -
ExchangeNASDAQ
CurrencyUSD
Last price$15.43
1-day move-0.90%
52-week range$12.73 - $39.89
Market cap$1.57B
From 52-week high-61.30%
Volume vs average0.9x
Falling Shares risk score19/100 (MODERATE)
CountryUnited States

Frequently asked questions

Why is Ultragenyx Pharmaceutical Inc. - falling today?

Ultragenyx Pharmaceutical Inc. - (NASDAQ:RARE) is down 0.90% at its latest quote and trades 61.3% below its 52-week high. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.

What is the Ultragenyx Pharmaceutical Inc. - share price today?

Ultragenyx Pharmaceutical Inc. - (NASDAQ:RARE) last traded at $15.43, a -0.90% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.

What is the 52-week range of Ultragenyx Pharmaceutical Inc. -?

Ultragenyx Pharmaceutical Inc. -'s 52-week low is $12.73 and its 52-week high is $39.89; the shares trade 61.3% below the high.

What is the market cap of Ultragenyx Pharmaceutical Inc. -?

Ultragenyx Pharmaceutical Inc. - has a market capitalisation of about $1.57B at the latest price.

What are the risks of investing in Ultragenyx Pharmaceutical Inc. -?

Falling Shares Intelligence rates Ultragenyx Pharmaceutical Inc. - 19/100 (MODERATE) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.

Data is compiled from public exchange feeds and may be delayed. Not investment advice.

Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com